Latest News about Generalized Anxiety Disorder
Recent news which mentions Generalized Anxiety Disorder
Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado
March 22, 2024
From Benzinga
From Benzinga
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
February 28, 2024
From Benzinga
MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
January 11, 2024
From Benzinga
MindMed's Phase 2b Trial For MM-120 In GAD Reaches Enrollment Milestone
September 12, 2023
Tickers
MNMD
From Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
May 19, 2023
Tickers
MNMD
From Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
May 09, 2023
Tickers
CYBN
From Benzinga
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
March 15, 2023
From Benzinga
Two New Studies On Classical Psychedelics: Grading Ketamine's Components, Tuning Down Psilocybin Dosing
January 24, 2023
Tickers
AWKNF
From Benzinga
Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results
January 18, 2023
Tickers
IXHL
From Benzinga
From Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
From Benzinga
MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
August 25, 2022
Tickers
MNMD
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.